Join our Newsletter — 33% off our NHI Course
Home› FAQ› Governance, Ownership & Risk› How should health systems build a drug diversion…
Governance, Ownership & Risk

How should health systems build a drug diversion monitoring program that actually catches incidents early?

← Back to all FAQ
By NHI Mgmt Group Editorial Team Updated September 26, 2026 Domain: Governance, Ownership & Risk

Health systems should combine clear governance, routine information sharing, and both manual and automated monitoring. A practical program needs a standing diversion committee or response team, defined expectations for staff, and regular review of dispensing and documentation data. The goal is to identify suspicious patterns early, reduce time spent chasing false leads, and create a repeatable process for investigation and follow-up.

Health systems need a diversion program that treats dispensing anomalies as an operational risk problem, not just a compliance task. The highest-value programs combine governed review, cross-functional escalation, and data that is specific enough to distinguish routine variance from genuine misuse. That means the monitoring model must be designed to surface signal early, not simply document cases after they are already obvious.

What makes early detection work is the pairing of human review with trend-based analytics. A standing committee or response team should own the process, but frontline pharmacists, nurses, and compliance staff need a shared playbook for what gets reviewed, what gets escalated, and what evidence must be retained. When that ownership is clear, false leads fall faster and suspicious patterns do not get lost between departments.

A useful program also relies on the right data shape. Dispensing records, administration records, wasting documentation, inventory movement, overrides, and exception logs should be reviewed together so investigators can compare what was ordered, what was removed, what was documented, and what was actually administered. The goal is pattern recognition across time, unit, shift, and employee, not a one-off search for a single missing dose. For broader incident learning, health systems can review The 52 NHI Breaches Report to see how weak accountability and poor visibility turn access into repeated compromise paths.

Risk and Threat Considerations

Drug diversion programs fail when they generate too many false positives, miss low-and-slow patterns, or depend on fragmented records that no one compares in a single workflow. The risk is not only medication loss, but delayed detection of staff impairment, repeated theft, and uncontrolled access to controlled substances.

Failure mechanism: Gaps between dispensing, wasting, administration, and inventory review let suspicious patterns blend into normal operational noise, especially when review ownership is unclear or thresholds are too blunt.

Impact: Early warning signs are missed, investigations start late, and the organisation absorbs patient-safety, regulatory, workforce, and reputational harm that becomes harder to contain as the pattern persists.

Standards & Framework Alignment

This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.

CIS Controls v8, NIST CSF 2.0 and NIST SP 800-53 Rev 5 set the governance and control requirements practitioners need to meet.

FrameworkControl / ReferenceRelevance
CIS Controls v8CIS-8 — Audit Log ManagementDiversion monitoring depends on reviewing logs and events across dispensing and administration systems.
Recommendation — Centralize and review dispensing-related logs to detect suspicious access and repeated anomalies early.
NIST CSF 2.0DE.CM-01 — The network, physical environment, and devices are monitored to find cybersecurity events and verify the effectiveness of protective measuresContinuous monitoring of dispensing and waste records is the core detection mechanism here.
GV.RR-01 — Organizational roles, responsibilities, and authorities to manage cybersecurity risk are established and communicatedA standing committee and defined escalation paths are essential to make diversion review actionable.
Recommendation — Monitor medication workflows continuously for anomaly patterns that indicate diversion. Assign clear ownership for diversion review, escalation, and case closure.
NIST SP 800-53 Rev 5AU-6 — Audit Record Review, Analysis, and ReportingRoutine analysis of dispensing and documentation records is the program's primary review control.
AU-12 — Audit Record GenerationThe program requires complete records from dispensing, wasting, and administration systems to support detection.
Recommendation — Review audit records for unusual controlled-substance transactions and reconcile discrepancies. Generate complete audit records for medication access, waste, and administration events.

Practitioner Guidance

What to prioritise: Start with the few data sources that most directly reveal mismatch, then add more only when the review team can act on them. If you cannot reliably reconcile dispensing, wasting, and administration, no alert threshold will be trustworthy.

What to verify: Confirm that every alert has an owner, a review SLA, and a documented closure path. Alerts that are not triaged on a schedule become backlog, not detection.

What good looks like: High-quality monitoring produces fewer, better escalations, clear root-cause patterns, and repeatable case handling across units and shifts, with enough context to support action without overinvestigating routine variation.

Practitioner takeaway: The most effective diversion programs are built to reconcile behavior, records, and accountability at the same time, because early detection depends on correlation, not isolated alarms.

Deepen Your Knowledge

Sign up to our weekly newsletter — get 33% off our NHI Foundation Level Course

    NHIMG Editorial Note
    Reviewed and updated by the NHIMG editorial team on September 26, 2026.
    NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org